Semaglutide Results After Month 6: Realistic Weight Loss Expectations

Introduction

Twenty-four weeks of semaglutide. You’\”ve been on the maintenance dose for a couple of months, the routine has settled, and the dramatic early changes have given way to a slower but steady rhythm. Month 6 is where the trajectory shows you what year 1 will look like.

STEP 1 (Wilding et al. 2021 NEJM) reported average weight loss of about 11.7 percent at week 24 in patients on 2.4 mg semaglutide. For a 240-pound starting weight, that’\”s 28 pounds gone. For 180, it’\”s 21 pounds.

The range is wide: top responders sit at 18 percent, lower responders at 7 percent. Both groups continue to lose through month 12, just at different paces.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

What Is the Average Semaglutide Weight Loss at 6 Months?

The realistic answer is 10 to 14 percent of starting body weight, with normal range from 7 to 18 percent. STEP 1 averaged 11.7 percent at week 24 on the maximum maintenance dose.

Quick Answer: STEP 1 reported about 11.7 percent average weight loss at week 24 on the 2.4 mg maintenance dose

For a 220-pound adult, this lands at 22 to 31 pounds. For 180 pounds, 18 to 25 pounds. For 280 pounds, 28 to 39 pounds.

Patients who reached 2.4 mg on schedule (week 17) tend to cluster around the STEP 1 average. Patients who held at lower doses due to side effects often sit 2 to 4 percentage points below the average.

Why Is the Rate of Loss Slowing at Month 6?

Two reasons. First, lower body weight means lower daily energy expenditure. A 200-pound person burns fewer calories per day than they did at 240 pounds, simply due to mass. The calorie deficit shrinks even without behavioral changes.

Second, the body increases counter-regulatory hormones as fat stores shrink. Leptin falls, ghrelin rises, and metabolic rate decreases slightly. GLP-1 drugs partly counteract this, but not fully.

The result is a typical curve that drops 2 pounds per week in months 2 and 3, then 1 to 1.5 pounds per week in months 4 through 6, then 0.5 to 1 pound per week thereafter.

What Dose Should You Be on at Month 6?

Most patients are on 2.4 mg, the maximum FDA-approved dose for chronic weight management. About 70 to 80 percent of STEP 1 participants who completed the trial were on 2.4 mg by week 24.

Some patients respond strongly to 1.7 mg and stay there. Others tolerate only 1.0 or 1.7 mg due to side effects. These patients still lose weight, just at a somewhat slower rate (typically 8 to 11 percent at month 6 instead of 12 to 14 percent).

The dose decision should be based on:

• Current rate of weight loss
• Side effect burden
• Remaining weight loss goal
• Cardiometabolic indications

How Visible Should Results Be at 6 Months?

For most patients, dramatically. The 10 to 14 percent loss represents:

• 2 to 3 clothing sizes down
• 4 to 7 inches lost at the waist
• Clear facial slimming
• Improvements in measured metrics like blood pressure and HbA1c

The STEP 1 trial reported systolic blood pressure drops of 6 to 8 mmHg and HbA1c improvements of 0.5 to 1 percentage point at this stage in patients with prediabetes.

How Do You Know If You’\”re Tracking on Target?

The clearest signal is whether you’\”ve hit at least 10 percent loss by week 24. Patients in this group are highly likely to continue losing through week 68. Patients below 8 percent at week 24 sometimes plateau early, requiring dose review or strategy changes.

The 5 percent at week 12 threshold remains the earlier predictor. Patients who hit it almost always hit 10 percent by week 24. Patients who didn’\”t may benefit from faster titration or attention to lifestyle variables.

What If Your Weight Loss Has Stalled at Month 6?

Plateaus lasting 2 to 3 weeks are normal. Plateaus lasting 4+ weeks at month 6 warrant a focused review:

• Protein intake (the single most common deficit)
• Sleep duration (7+ hours)
• Stress levels (cortisol blunts weight loss)
• Alcohol intake (often quietly increases)
• Calorie creep (appetite suppression dips between doses)
• Strength training (preserves metabolic rate)
• Concurrent medications

A 2024 review found that roughly 40 percent of GLP-1 plateaus at month 6 resolve with dietary protein increases alone. Another 20 percent resolve with sleep improvements.

If lifestyle review doesn’\”t unblock it, your provider may recommend continuing on 2.4 mg with the expectation of further loss over months 7 to 12, or considering a switch to tirzepatide.

Key Takeaway: Weight loss typically slows from 1.5 to 1 pound per week between months 4 and 6

How Do You Protect Lean Mass?

Resistance training is non-negotiable by month 6. A 2024 review in Lancet Diabetes & Endocrinology found GLP-1 patients with consistent strength training preserved roughly twice as much lean mass as sedentary patients.

The protocol:

• 3 strength sessions weekly, focused on compound lifts
• Protein at 0.7 to 1 gram per pound of target weight
• 7 to 9 hours of sleep
• 7,000 to 10,000 steps daily for non-exercise activity

Patients hitting all four markers maintain better function, metabolic rate, and long-term outcomes. Patients who skip the training often regret it later when goal weight is reached but body composition is poor.

How Do Cardiometabolic Markers Respond by Month 6?

Strongly. By week 24, typical semaglutide patient changes include:

• HbA1c drop of 0.7 to 1.3 percentage points in patients with prediabetes
• Systolic BP drop of 6 to 9 mmHg
• LDL cholesterol decrease of 7 to 12 percent
• Triglyceride decrease of 20 to 30 percent
• Fasting glucose improvement

Many patients reduce or stop antihypertensive and lipid medications around month 6. This should always be coordinated with the prescribing provider rather than self-managed.

The SELECT trial (Lincoff et al. 2023 NEJM) showed semaglutide reduced major cardiovascular events by 20 percent over a median 3.3 years in patients with established cardiovascular disease, with most of the benefit independent of weight loss magnitude.

What About Year 2 Planning?

Year 1 typically delivers 14 to 17 percent total loss for adherent patients on 2.4 mg. Year 2 adds another 1 to 3 percent on average, with the bulk of effort shifting to maintenance.

The question of how long to stay on semaglutide is increasingly answered by the data: long-term, similar to other chronic disease medications. STEP 4 (Rubino et al. 2021 JAMA) showed that patients who stopped semaglutide regained roughly two-thirds of their lost weight within a year, while those who continued maintained their losses.

The reframe is helpful. Semaglutide isn’\”t a 12-month weight loss tool. It’\”s a chronic therapy for a chronic disease (obesity), comparable to antihypertensives for hypertension.

How Does Semaglutide Compare to Tirzepatide at 6 Months?

SURMOUNT-5 (Aronne et al. 2024 NEJM) directly compared the two. At week 24, tirzepatide produced about 15 percent loss vs 11 percent for semaglutide. The gap continues widening, reaching 20.2 percent vs 13.7 percent at week 72.

Tirzepatide outperforms for raw weight loss. Semaglutide has the strongest cardiovascular outcome data (SELECT) and chronic kidney disease data (FLOW). For most patients, the choice is individualized rather than a single right answer.

TrimRx offers both options and uses a free assessment quiz to route patients toward the most appropriate treatment based on goals and medical history.

Bottom line: Cardiometabolic improvements often substantial by 6 months

FAQ

Is 25 Pounds in 6 Months a Good Semaglutide Result?

For a 220-pound starting weight, 25 pounds is just over 11 percent, right at the STEP 1 average. For 280 pounds, 25 pounds is just under 9 percent, slightly below average. For 180 pounds, 25 pounds is 14 percent, on the higher end.

Should I Be at My Goal Weight by 6 Months?

Probably not unless your goal weight is modest. Most patients reach final goal between months 12 and 18. Six months is typically the midpoint of active weight loss.

Do I Need to Take a Break From Semaglutide?

No. Continuous treatment is the standard. Drug holidays cause weight regain without benefit. If side effects are an issue, dose reduction is preferable to pausing.

Will My Weight Loss Continue?

Usually yes, but slowly. Most patients add another 3 to 5 percent between months 6 and 12, then taper toward maintenance.

Should I Drop to a Lower Dose at 6 Months?

Only if you’\”ve hit goal weight or are very close. Premature dose reduction often causes weight creep. Stay at the dose that produced your loss until weight has been stable for 3 to 6 months.

Are There Safety Concerns at 6 Months?

Tolerability data through 68 weeks (STEP 1) and 3 years (SELECT) has been strong. Routine monitoring of basic labs is appropriate. Pancreatitis, gallbladder issues, and severe gastrointestinal events are uncommon.

Can I Switch From Semaglutide to Tirzepatide at 6 Months?

Yes, this is increasingly common. The switch usually requires a brief washout and restart titration on tirzepatide. Your provider can guide the transition.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.